Riskpilot← Back to searchSign inGet full accessMANIKLIS AB
ABActiveOrg 5593767451Fågelbovägen 16Medical specialists activities · NACE 8622Est. 20221-4 employees
Revenue 2025
SEK 886K
-29% vs 2024
EBITDA margin
11.5%
-78% vs 2024
Equity ratio
51.7%
Financial strength
Net profit 2025
SEK 404K
+35% vs 2024
| Revenue | SEK 886K | -29% |
| EBITDA | SEK 102K | -78% |
| Net profit | SEK 404K | +35% |
| Total assets | SEK 1,1M | +19% |
| Equity | SEK 589K | +53% |
| Employees | — | — |
Legal name
MANIKLIS AB
Org number
5593767451
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
21 april 2022
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska verka inom läkartjänster inom hälso-, frisk-, och sjukvård och tillhandahålla sjukvårdspersonal och konsultationer inom sjukvård, personlig utveckling, ledarskap, ekonomi och marknadsföring. Företaget ska bedriva forskningsuppdrag, undervisning och föreläsningar, publikation av artiklar och böcker, samt journalist- och redaktörsarbete. Företaget ska bedriva handel med värdepapper, förvalta kapital och därmed förenlig verksamhet. Företaget ska verka inom utveckling av kultur så som drama, skrivande och konst.
Address
Fågelbovägen 16
Email
anna@kanold.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 553 | 1 254 | 886 |
| Staff expenses | −257 | −752 | −749 |
| EBITDA | 268 | 473 | 102 |
| Depreciation & amort. | — | — | — |
| EBIT | 268 | 473 | 102 |
| Net financials | 0 | 2 | 343 |
| Profit before tax | 203 | 376 | 421 |
| Tax | −42 | −77 | −17 |
| Net profit | 161 | 299 | 404 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 418 | 953 | 1 138 |
| Equity | 186 | 385 | 589 |
| Long-term debt | — | — | — |
| Short-term debt | 167 | 404 | 360 |
| Total debt | 167 | 404 | 360 |
EBITDA margin
11.5%
This company
15.8%
Market median
-27% vs market
20232025
Equity ratio
51.7%
This company
38.2%
Market median
+35% vs market
20232025
Return on equity
68.6%
This company
18.4%
Market median
+273% vs market
20232025
Net profit margin
45.6%
This company
8.1%
Market median
+463% vs market
20232025
Asset turnover
0.78×
This company
1.12×
Market median
-30% vs market
20232025
Debt / equity
0.93×
This company
0.62×
Market median
+50% vs market
20232025
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MANIKLIS AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leo Mattias Kanold | Deputy Board Member | 0 companies |
| Anna Maria Emma Filippa Kanold | Board of Directors | 0 companies |